Drug application
PIPERACILLIN AND TAZOBACTAM (PIPERACILLIN SODIUM, TAZOBACTAM SODIUM)
Drugs@FDA ANDA 217409 · EUGIA PHARMA
Key facts
| Drug name | PIPERACILLIN AND TAZOBACTAM |
|---|---|
| Active ingredients | PIPERACILLIN SODIUM, TAZOBACTAM SODIUM |
| Application type | ANDA |
| Application number | 217409 |
| Company | EUGIA PHARMA |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL |
| Marketing status | Discontinued |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Oct 12, 2023 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 10–99 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.